Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4701
MGE Energy Inc
MGEE
$2.95B
| $950K | ﹤0.01% |
12,925
+1,009
| +8% | +$79K |
|
4702
Motorcar Parts of America
MPAA
$218M
| $950K | ﹤0.01% |
48,713
-8,989
| -16% | -$188K |
|
|
VMRK
4703
PUT
Vivmark Residential
VMRK
$26.1B
| $947K | ﹤0.01% |
11,700
-19,700
| -63% | -$1.63M |
|
4704
Saga Communications
SGA
$56.6M
| $947K | ﹤0.01% |
41,626
-26,951
| -39% | -$610K |
|
|
ORTX
4705
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $947K | ﹤0.01% |
41,171
+38,934
| +1,740% | +$1.16M |
|
|
PBIP
4706
DELISTED
Prudential Bancorp, Inc.
PBIP
| $947K | ﹤0.01% |
62,065
-31,819
| -34% | -$454K |
|
|
GRDI
4707
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
| $946K | ﹤0.01% |
97,152
+60,000
| +161% | +$581K |
|
4708
REX American Resources
REX
$1.36B
| $945K | ﹤0.01% |
70,956
+54,096
| +321% | +$731K |
|
|
GPACU
4709
DELISTED
Global Partner Acquisition Corp II Unit
GPACU
| $943K | ﹤0.01% |
95,369
-498,196
| -84% | -$4.92M |
|
4710
Allient
ALNT
$1.58B
| $942K | ﹤0.01% |
30,110
+15,032
| +100% | +$492K |
|
|
MOFG
4711
DELISTED
MidWestOne Financial Group
MOFG
| $942K | ﹤0.01% |
31,226
+2,083
| +7% | +$60.8K |
|
4712
Milestone Scientific
MLSS
$44.5M
| $939K | ﹤0.01% |
501,959
-318,933
| -39% | -$590K |
|
|
OTRK
4713
DELISTED
Ontrak
OTRK
| $939K | ﹤0.01% |
1,039
-702
| -40% | -$1.25M |
|
|
CWAN
4714
DELISTED
Clearwater Analytics
CWAN
| $937K | ﹤0.01% |
+36,573
| New | +$939K |
|
|
AVNS
4715
PUT
DELISTED
Avanos Medical
AVNS
| $936K | ﹤0.01% |
+30,000
| New | +$1.02M |
|
4716
Orion
OEC
$358M
| $934K | ﹤0.01% |
51,252
-598,440
| -92% | -$10.7M |
|
4717
Healthcare Services Group
HCSG
$1.54B
| $933K | ﹤0.01% |
37,343
+13,151
| +54% | +$356K |
|
|
PHAS
4718
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $932K | ﹤0.01% |
299,816
+92,273
| +44% | +$308K |
|
4719
MainStreet Bancshares
MNSB
$179M
| $931K | ﹤0.01% |
38,807
-35,815
| -48% | -$844K |
|
|
TSC
4720
DELISTED
TriState Capital Holdings, Inc.
TSC
| $931K | ﹤0.01% |
44,013
-6,452
| -13% | -$131K |
|
4721
Full House Resorts
FLL
$75.5M
| $930K | ﹤0.01% |
87,670
-7,017
| -7% | -$59.9K |
|
4722
PUT
Fastly Inc
FSLY
$3.67B
| $930K | ﹤0.01% |
23,000
| – | – |
|
4723
Biglari Holdings Class B
BH
$1.2B
| $927K | ﹤0.01% |
5,397
+816
| +18% | +$137K |
|
4724
Enterprise Financial Services Corp
EFSC
$2.3B
| $927K | ﹤0.01% |
20,465
-170,732
| -89% | -$7.65M |
|
4725
Vista Energy
VIST
$7.76B
| $927K | ﹤0.01% |
184,300
+62,821
| +52% | +$276K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.